Trevi Therapeutics TRVI
$13.35 −$0.37 (-2.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.35 0.00%
Open$13.58
Prev close$13.72
Day range$13.23 – $13.90
Volume2.09M
Market cap$1.90B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts7
Average target$27.71+107.6% vs. price
- Buy 100%
Low $23.00Now $13.35Avg $27.71High $36.00
Recent rating changes
The last 20 actions on file set price targets from $23.00 to $40.00, averaging $27.95.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | JonesTrading | BUY | $28.00 |
| 10 Nov 2026 | Morgan Stanley | BUY | $23.00 |
| 10 Nov 2026 | Stifel | BUY | $30.00 |
| 10 Nov 2026 | Needham | BUY | $23.00 |
| 10 Nov 2026 | BMO Capital | BUY | $36.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $24.00 |
| 9 Nov 2026 | Cantor Fitzgerald | BUY | $30.00 |
| 22 Oct 2026 | JonesTrading | BUY | $28.00 |
| 6 Oct 2026 | BMO Capital | BUY | $36.00 |
| 21 Sep 2026 | H.C. Wainwright | BUY | $24.00 |
| 13 Aug 2026 | JonesTrading | BUY | $28.00 |
| 11 Aug 2026 | H.C. Wainwright | BUY | $24.00 |
| 10 Aug 2026 | Morgan Stanley | BUY | $23.00 |
| 7 Aug 2026 | Raymond James | BUY | $40.00 |
| 7 Aug 2026 | Morgan Stanley | BUY | $23.00 |
| 7 Aug 2026 | Stifel | BUY | $30.00 |
| 7 Aug 2026 | Needham | BUY | $23.00 |
| 7 Aug 2026 | B. Riley Securities | BUY | $31.00 |
| 7 Aug 2026 | Oppenheimer | BUY | $25.00 |
| 6 Aug 2026 | Cantor Fitzgerald | BUY | $30.00 |
No comments yet — be the first to weigh in on TRVI.
Sign in to join the discussion.